SCHEMBL5147669

SCHEMBL5147669

O=C(Cl)Oc1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.55
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
TTR P02766 3/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
NR1I2 O75469 1/20 0.50
LMNA P02545 1/20 0.50
PGR P06401 1/20 0.50
HSP90AA1 P07900 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
HSPA5 P11021 1/20 0.50
CBR1 P16152 1/20 0.50
TBXA2R P21731 1/20 0.50
SLC6A2 P23975 1/20 0.50
AGTR1 P30556 1/20 0.50
SLC6A3 Q01959 1/20 0.50
TSHR P16473 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MRGPRX4 Q96LA9 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL123483 0.85 TDP1 (0.56) TDP1KMT2AMEN1TTRMAPT
SCHEMBL30225290 0.85 TDP1 (0.56) TDP1KMT2AMEN1TTRMAPT
SCHEMBL31572520 0.85 TDP1 (0.56) TDP1KMT2AMEN1TTRMAPT
SCHEMBL618918 0.85 TDP1 (0.56) TDP1KMT2AMEN1TTRMAPT
SCHEMBL3129607 0.83 TDP1 (0.55) TDP1KMT2AMEN1TTRMAPT
SCHEMBL3129615 0.83 TDP1 (0.59) TDP1KMT2AMEN1TTRMAPT
SCHEMBL11717445 0.83 ALDH1A1 (0.45) TDP1KMT2AMEN1LMNATSHR
SCHEMBL134715 0.82 KMT2A (0.57) TDP1KMT2AMEN1TTRMAPT
SCHEMBL18697333 0.82 TDP1 (0.53) TDP1KMT2AMEN1TTRMAPT
Hydrochloric Acid SCHEMBL11842989 0.82 TDP1 (0.58) TDP1KMT2AMEN1TTRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276017-A1 Thiadiazoline Derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2007-11-29 US disclosed
EP-1632484-A1 THIADIAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-03-08 EP disclosed
US-20020082254-A1 Compounds for treating disorders where a decreased level of plasma FFA is desired NOVO NORDISK A/S (DK) 2002-06-27 US disclosed
WO-2001087843-A1 COMPOUNDS FOR TREATING DISORDERS WHERE A DECREASED LEVEL OF PLASMA FFA IS DESIRED NOVO NORDISK A/S (DK) 2001-11-22 WO disclosed
US-5600025-A CHEMICAL INTERMEDIATES FOR NONWAXY FUEL AND LUBRICANT ADDITIVES CONTAINING ALKYLPHENYL POLY(OXYPROPYLENE) AMINOCARBAMATES; ANTIDEPOSIT AGENTS CHEVRON CHEMICAL COMPANY (US) 1997-02-04 US disclosed
EP-0404876-B1 LONG-CHAIN ALIPHATIC HYDROCARBYL AMINE ADDITIVES HAVING AN OXY-CARBONYL CONNECTING GROUP CHEVRON RES & TECH (US) 1995-02-15 EP disclosed
EP-0419488-A4 LUBRICATING OIL COMPOSITIONS AND FUEL COMPOSITIONS CONTAINING SUBSTANTIALLY STRAIGHT CHAIN PINWHEEL ALKYLPHENYL POLY(OXYPROPYLENE) AMINOCARBAMATES CHEVRON RES (US) 1994-11-23 EP disclosed
US-5364546-A Dispersants, improved compatibility CHEVRON RESEARCH COMPANY (US) 1994-11-15 US disclosed
US-5322529-A Liquid additive; internal combustion engines CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1994-06-21 US disclosed
US-5312965-A Dispersants CHEVRON RESEARCH COMPANY (US) 1994-05-17 US disclosed
EP-0396573-A4 FUEL COMPOSITIONS AND LUBRICATING OIL COMPOSITIONS CONTAINING VERY LONG CHAIN ALKYLPHENYL POLY(OXYALKYLENE) AMINOCARBAMATES 1990-11-28 EP disclosed
EP-0396573-A1 FUEL COMPOSITIONS AND LUBRICATING OIL COMPOSITIONS CONTAINING VERY LONG CHAIN ALKYLPHENYL POLY(OXYALKYLENE) AMINOCARBAMATES. CHEVRON RES (US) 1990-11-14 EP disclosed
WO-1990007564-A1 LUBRICATING OIL COMPOSITIONS AND FUEL COMPOSITIONS CONTAINING SUBSTANTIALLY STRAIGHT CHAIN PINWHEEL ALKYLPHENYL POLY(OXYPROPYLENE) AMINOCARBAMATES CHEVRON RESEARCH COMPANY (US) 1990-07-12 WO disclosed
US-4933485-A DISPERSANT ADDITIVES POSSESSING IMPROVED COMPATIBILITY CHEVRON RESEARCH COMPANY (US) 1990-06-12 US disclosed
WO-1990004582-A1 FUEL COMPOSITIONS AND LUBRICATING OIL COMPOSITIONS CONTAINING VERY LONG CHAIN ALKYLPHENYL POLY(OXYALKYLENE) AMINOCARBAMATES CHEVRON RESEARCH COMPANY (US) 1990-05-03 WO disclosed
WO-1990002785-A1 LONG-CHAIN ALIPHATIC HYDROCARBYL AMINE ADDITIVES HAVING AN OXY-CARBONYL CONNECTING GROUP CHEVRON RESEARCH COMPANY (US) 1990-03-22 WO disclosed
US-4881945-A LUBRICATING OIL COMPATIBILITY CHEVRON RESEARCH COMPANY (US) 1989-11-21 US disclosed
EP-0297996-A2 Lubricating oil compositions and fuel compositions containing substantially straight chain alkylphenyl poly(oxypropylene) aminocarbamates CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1989-01-04 EP disclosed
US-4376731-A 2-NITRILES THEREOF BOEHRINGER MANNHEIM GMBH (DE) 1983-03-15 US disclosed
US-3986973-A CYANOFORMATES AND CYANOFORMAMIDES AS BLEACH ACTIVATORS AMERICAN CYANAMID COMPANY (US) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276017-A1 Thiadiazoline Derivative BRD7, NR3C2, NR5A2 TDP1 3187/4885KMT2A 3066/4885MEN1 2331/4885
US-20020082254-A1 Compounds for treating disorders where a decreased level of plasma FFA is desired FABP1, FFAR2, FFAR1 TDP1 4063/4885KMT2A 4207/4885MEN1 2075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.